At the news
? NEUTRALIMPACT 2/10 144 filed Jun 15, 2026 at 16:59 ET
Margaret A. Horn, an officer at Revolution Medicines, filed a Form 144 to sell 90,000 common shares (~$13.85M at filing price). The sale is pursuant to a Rule 10b5-1 plan, with shares acquired upon exercise of stock options. The advance notice signals planned monetization of equity compensation, not an opportunistic sale.
- Insider: Margaret A. Horn (Officer)
- Shares proposed for sale: 90,000 common shares
- Estimated value: approx. $13.85 million ($153.87 per share)
- Sale plan: Rule 10b5-1 trading arrangement adopted March 12, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access